Skip to content

Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland

Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01150240
Enrollment
800
Registered
2010-06-24
Start date
2006-10-31
Completion date
Unknown
Last updated
2016-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Immunodeficiency Disease

Keywords

Primary Immunodeficiency Disease

Brief summary

A Swiss national, multi-centre, online patient and research database will be created, using the existing ESID database server system. This database contains disease-specific data from patients with primary (inborn) immunodeficiency diseases (PID).

Detailed description

The project aims to compile clinical and laboratory data of patients with primary immunodeficiencies (PID) in order to improve diagnosis, classification, prognosis and therapy. The online technology offers features not available in former databases such as access control,security functionality, and maintenance of data integrity during transactions and system errors, online back up, online optimization, scalability and online SQL-queries as well as a long term documentation of patients. Furthermore the database can be used for the submission and storage of molecular diagnostic results and thus allow the compilation of genotype and phenotype observations, which is of essential and immediate use for the patient himself and patient care. An attending physician may gain information on similar cases of a rare PID disease in Switzerland and European countries and use these insights for therapy. In addition, it will be possible to obtain an insight on side effects. Thus, the system also meets the requirements of an optimal platform for Phase IV studies of post-licensing drug surveillance-programs.

Interventions

None listed

Sponsors

University of Basel
CollaboratorOTHER
University of Bern
CollaboratorOTHER
University Hospital, Geneva
CollaboratorOTHER
University of Lausanne
CollaboratorOTHER
Cantonal Hospital of St. Gallen
CollaboratorOTHER
University of Zurich
Lead SponsorOTHER

Study design

Observational model
COHORT

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Primary Immunodeficiency Disease (PID)

Exclusion criteria

* None

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026